Effects of a physical activity behavior change intervention on inflammation and related health outcomes in breast cancer survivors: Pilot randomized trial

Integrative Cancer Therapies

Volumn 12, Issue 4, 2013, Pages 323-335

  Rogers, Laura Q ^a   Fogleman, Amanda ^a   Trammell, Rita ^a   Hopkins Price, Patricia ^a   Vicari, Sandy ^a   Rao, Krishna ^a   Edson, Billie ^a   Verhulst, Steven ^a   Courneya, Kerry S ^b   Hoelzer, Karen ^c  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Springfield Clinic   (United States)

Author keywords

cytokine; exercise; inflammation; intervention; oncology; survivorship

Indexed keywords

ADIPONECTIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVOR; CARDIORESPIRATORY FITNESS; CONTROLLED STUDY; FITNESS; HUMAN; HYPOTHESIS; INFLAMMATION; MAJOR CLINICAL STUDY; PATIENT CARE; PHYSICAL ACTIVITY; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SLEEP; TREATMENT OUTCOME;

CYTOKINE; EXERCISE; INFLAMMATION; INTERVENTION; ONCOLOGY; SURVIVORSHIP;

ADULT; AGED; BREAST NEOPLASMS; EXERCISE THERAPY; FEMALE; HEALTH BEHAVIOR; HEALTH STATUS; HUMANS; INFLAMMATION; MIDDLE AGED; MOTOR ACTIVITY; PILOT PROJECTS; SURVIVORS; TREATMENT OUTCOME;

EID: 84879377471     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735412449687     Document Type: Article

References (81)

1. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA.. Physical activity and survival after breast cancer diagnosis. JAMA. 2005 ; 293: 2479-2486
2. McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS.. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006 ; 175: 34-41
3. Schmitz KH, Holtzman J, Courneya KS, Masse LC, Duval S, Kane R.. Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2005 ; 14: 1588-1595
4. Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH.. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv. 2010 ; 4: 87-100
5. Andrykowski MA, Curran SL, Lightner R.. Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med. 1998 ; 21: 1-18
6. Kirkova J, Walsh D.. Cancer symptom clusters: a dynamic construct. Support Care Cancer. 2007 ; 15: 1011-1013
7. Patrick DL, Ferketich SL, Frame PS, et al.. National Institutes of Health State-of-the-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue ; 2003 July 15-17, 2002 ; 2003. 1110.
8. Lorton D, Lubahn CL, Estus C, et al. Bidirectional communication between the brain and the immune system: implications for physiological sleep and disorders with disrupted sleep. Neuroimmunomodulation. 2006 ; 13: 357-374
9. Santos RV, Tufik S, De Mello MT.. Exercise, sleep and cytokines: is there a relation?. Sleep Med Rev. 2007 ; 11: 231-239
10. Schubert C, Hong S, Natarajan L, Mills PJ, Dimsdale JE.. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav Immun. 2007 ; 21: 413-427
11. Silver HJ, Dietrich MS, Murphy BA.. Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head Neck. 2007 ; 29: 893-900
12. Cesari M, Penninx BW, Pahor M, et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004 ; 59: 242-248
13. Ferrucci L, Penninx BW, Volpato S, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc. 2002 ; 50: 1947-1954
14. Pedersen M, Bruunsgaard H, Weis N, et al. Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev. 2003 ; 124: 495-502
15. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin- 6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002 ; 57: M326 - M332
16. Knupfer H, Preiss R.. Significance of interleukin-6 (IL-6) in breast cancer (review). Breast Cancer Res Treat. 2007 ; 102: 129-135
17. Braithwaite D, Satariano WA, Sternfeld B, et al. Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst. 2010 ; 102: 1468-1477
18. Gallicchio L, Kalesan B.. Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res. 2009 ; 18: 148-158
19. Thornton LM, Andersen BL, Carson WE. Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis. Cancer Immunol Immunother. 2008 ; 57: 1471-1481
20. Hursting SD, Berger NA.. Energy balance, host-related factors, and cancer progression. J Clin Oncol. 2010 ; 28: 4058-4065
21. Weisberg SP, Hunter D, Huber R, et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest. 2006 ; 116: 115-124
22. Garaulet M, Hernandez-Morante JJ, de Heredia FP, Tebar FJ.. Adiponectin, the controversial hormone. Public Health Nutr. 2007 ; 10: 1145-1150
23. Frank LL, Sorensen BE, Yasui Y, et al. Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res. 2005 ; 13: 615-625
24. Friedenreich CM, Neilson HK, Woolcott CG, et al. Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women. Endocr Relat Cancer. 2011 ; 18: 357-369
25. Irwin ML, McTiernan A, Bernstein L, et al. Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2005 ; 14: 2881-2888
26. Ligibel JA, Giobbie-Hurder A, Olenczuk D, et al. Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors. Cancer Causes Control. 2009 ; 20: 1523-1528
27. Courneya KS.. Efficacy, effectiveness, and behavior change trials in exercise research. Int J Behav Nutr Phys Act. 2010 ; 7: 81
28. Carmack Taylor CL, Demoor C, Smith MA, et al. Active for Life After Cancer: a randomized trial examining a lifestyle physical activity program for prostate cancer patients. Psychooncology. 2006 ; 15: 847-862
29. Damush TM, Perkins A, Miller K.. The implementation of an oncologist referred, exercise self-management program for older breast cancer survivors. Psychooncology. 2006 ; 15: 884-890
30. Demark-Wahnefried W, Clipp EC, Morey MC, et al. Lifestyle intervention development study to improve physical function in older adults with cancer: outcomes from Project LEAD. J Clin Oncol. 2006 ; 24: 3465-3473
31. Matthews CE, Wilcox S, Hanby CL, et al. Evaluation of a 12-week home-based walking intervention for breast cancer survivors. Support Care Cancer. 2007 ; 15: 203-211
32. Midtgaard J, Tveteras A, Rorth M, Stelter R, Adamsen L.. The impact of supervised exercise intervention on short-term postprogram leisure time physical activity level in cancer patients undergoing chemotherapy: 1- and 3-month follow-up on the body & cancer project. Palliat Support Care. 2006 ; 4: 25-35
33. Pinto BM, Frierson GM, Rabin C, Trunzo JJ, Marcus BH.. Home-based physical activity intervention for breast cancer patients. J Clin Oncol. 2005 ; 23: 3577-3587
34. Vallance JK, Courneya KS, Plotnikoff RC, Yasui Y, Mackey JR. Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors. J Clin Oncol. 2007 ; 25: 2352-2359
35. Wilson RW, Taliaferro LA, Jacobsen PB.. Pilot study of a self-administered stress management and exercise intervention during chemotherapy for cancer. Support Care Cancer. 2006 ; 14: 928-935
36. Bruunsgaard H.. Physical activity and modulation of systemic low-level inflammation. J Leukoc Biol. 2005 ; 78: 819-835
37. Petersen AM, Pedersen BK.. The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol. 2006 ; 57: 43-51
38. Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA, Pedersen BK.. IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab. 2002 ; 283: E1272 - E1278
39. Ullum H, Haahr PM, Diamant M, Palmo J, Halkjaer-Kristensen J, Pedersen BK.. Bicycle exercise enhances plasma IL-6 but does not change IL-1 alpha, IL-1 beta, IL-6, or TNF-alpha pre-mRNA in BMNC. J Appl Physiol. 1994 ; 77: 93-97
40. Ploeger HE, Takken T, de Greef MH, Timmons BW.. The effects of acute and chronic exercise on inflammatory markers in children and adults with a chronic inflammatory disease: a systematic review. Exerc Immunol Rev. 2009 ; 15: 6-41
41. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J Appl Physiol. 2005 ; 98: 1534-1540
42. Hutnick NA, Williams NI, Kraemer WJ, et al. Exercise and lymphocyte activation following chemotherapy for breast cancer. Med Sci Sports Exerc. 2005 ; 37: 1827-1835
43. Demark-Wahnefried W, Clipp EC, Lipkus IM, et al. Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J Clin Oncol. 2007 ; 25: 2709-2718
44. Payne JK, Held J, Thorpe J, Shaw H.. Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. Oncol Nurs Forum. 2008 ; 35: 635-642
45. Demark-Wahnefried W, Case LD, Blackwell K, et al. Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin Breast Cancer. 2008 ; 8: 70-79
46. Pierce BL, Neuhouser ML, Wener MH, et al. Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat. 2008 ; 114: 155-167
47. Sprod LK, Palesh OG, Janelsins MC, et al. Exercise, sleep quality, and mediators of sleep in breast and prostate cancer patients receiving radiation therapy. Community Oncol. 2010 ; 7: 463-471
48. Olson TP, Dengel DR, Leon AS, Schmitz KH.. Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women. Int J Obes (Lond). 2007 ; 31: 996-1003
49. Chatzinikolaou A, Fatouros IG, Gourgoulis V, et al. Time course of changes in performance and inflammatory responses after acute plyometric exercise. J Strength Cond Res. 2010 ; 24: 1389-1398
50. Opp MR.. Sleep and psychoneuroimmunology. Neurol Clin. 2006 ; 24: 493-506
51. Feldmann M, Maini RN.. Lasker Clinical Medical Research Award: TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat Med. 2003 ; 9: 1245-1250
52. George J, Cannon T, Lai V, et al. Cancer cachexia syndrome in head and neck cancer patients: part II. Pathophysiology. Head Neck. 2007 ; 29: 497-507
53. Roubenoff R, Grinspoon S, Skolnik PR, et al. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men. Am J Physiol Endocrinol Metab. 2002 ; 283: E138 - E145
54. Pedersen BK, Akerstrom TC, Nielsen AR, Fischer CP.. Role of myokines in exercise and metabolism. J Appl Physiol. 2007 ; 103: 1093-1098
55. Chavey C, Bibeau F, Gourgou-Bourgade S, et al. Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res. 2007 ; 9: R15
56. Kozlowski L, Zakrzewska I, Tokajuk P, Wojtukiewicz MZ.. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Rocz Akad Med Bialymst. 2003 ; 48: 82-84
57. Ray A, Cleary MP.. Leptin as a potential therapeutic target for breast cancer prevention and treatment. Expert Opin Ther Targets. 2010 ; 14: 443-451
58. Korner A, Pazaitou-Panayiotou K, Kelesidis T, et al. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab. 2007 ; 92: 1041-1048
59. Oh SW, Park CY, Lee ES, et al. Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study. Breast Cancer Res. 2011 ; 13: R34
60. Bruunsgaard H, Bjerregaard E, Schroll M, Pedersen BK.. Muscle strength after resistance training is inversely correlated with baseline levels of soluble tumor necrosis factor receptors in the oldest old. J Am Geriatr Soc. 2004 ; 52: 237-241
61. Rogers LQ, Hopkins-Price P, Vicari S, et al. Physical activity and health outcomes three months after completing a physical activity behavior change intervention: persistent and delayed effects. Cancer Epidemiol Biomarkers Prev. 2009 ; 18: 1410-1418
62. Rogers LQ, Hopkins-Price P, Vicari S, et al. A randomized trial to increase physical activity in breast cancer survivors. Med Sci Sports Exerc. 2009 ; 41: 935-946
63. Rogers LQ, Vicari S, Courneya KS.. Lesson learned in the trenches: facilitating exercise adherence among breast cancer survivors in a group setting. Cancer Nurs. 2010 ; 33: E10 - E17
64. Freedson PS, Melanson E, Sirard J.. Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc. 1998 ; 30: 777-781
65. Sirard JR, Melanson EL, Li L, Freedson PS.. Field evaluation of the Computer Science and Applications, Inc. physical activity monitor. Med Sci Sports Exerc. 2000 ; 32: 695-700
66. Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ. Principles of Exercise Testing and Interpretation Including Pathophysiology and Clinical Applications. 3 rd ed.Baltimore, MD: Lippincott Williams & Wilkins; 1999. Baltimore, MD: Lippincott Williams & Wilkins ; 1999 :
67. Hann DM, Jacobsen PB, Azzarello LM, et al. Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res. 1998 ; 7: 301-310
68. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ.. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 ; 28: 193-213
69. Ray CA, Bowsher RR, Smith WC, et al. Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum. J Pharm Biomed Anal. 2005 ; 36: 1037-1044
70. Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE.. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry. 2001 ; 45: 27-36
71. Liu MY, Xydakis AM, Hoogeveen RC, et al. Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clin Chem. 2005 ; 51: 1102-1109
72. Tuck MK, Chan DW, Chia D, et al. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res. 2009 ; 8: 113-117
73. de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V.. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol. 2009 ; 10: 52
74. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2 nd ed.Hillsdale, NJ: Lawrence Erlbaum; 1988. Hillsdale, NJ: Lawrence Erlbaum ; 1988 :
75. Lubin JH, Colt JS, Camann D, et al. Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect. 2004 ; 112: 1691-1696
76. Pusztai L, Mendoza TR, Reuben JM, et al. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine. 2004 ; 25: 94-102
77. Zhang GJ, Adachi I.. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res. 1999 ; 19: 1427-1432
78. Dossus L, Becker S, Achaintre D, Kaaks R, Rinaldi S.. Validity of multiplex-based assays for cytokine measurements in serum and plasma from "non-diseased" subjects: comparison with ELISA. J Immunol Methods. 2009 ; 350: 125-132
79. Tilg H, Dinarello CA, Mier JW.. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today. 1997 ; 18: 428-432
80. Walsh NP, Gleeson M, Shephard RJ, et al. Position statement. Part one: immune function and exercise. Exerc Immunol Rev. 2011 ; 17: 6-63
81. Trost SG, Owen N, Bauman AE, Sallis JF, Brown W.. Correlates of adults' participation in physical activity: review and update. Med Sci Sports Exerc. 2002 ; 34: 1996-2001